AVH Insider Trading (AVITA Medical)
Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): A$25,168.26
Insider Selling (Last 12 Months): A$0.00
AVITA Medical Share Price & Price History
Current Price: A$0.00
Price Change: +0.30 (1.20%)
As of 05/13/2020 01:00 AM ET
Warning: The Last Value Play Gone After August?
From Oxford Club | Ad
In this market...There's ONE STOCK (priced at just under $2) that could be $20 and STILL be a bargain. It brought in more income – including equity sales - in the last 12 months than Disney, Square or Tesla.
But a key announcement in August could send this stock rocketing skyward
Get the Details Now.
AVITA Medical Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 9/20/2021 | Suzanne Crowe | Insider | Buy | 5,330 | A$4.72 | A$25,168.26 | | |
| 6/4/2021 | Michael Perry | Insider | Exercise | 4,750,700 | A$4.47 | A$21,235,629.00 | | |
| 6/2/2020 | Michael Perry | Insider | Issued | 10,306,256 | A$0.47 | A$4,843,940.32 | | |
| 3/3/2020 | Michael Perry | Insider | Exercise | 6,850,484 | A$0.60 | A$4,076,037.98 | | |
| 12/3/2019 | Michael Perry | Insider | Issued | 39,554,252 | A$0.58 | A$22,743,694.90 | | |
[Big Reveal] Secret Strategy Makes Investors "Very, Very Rich
From Oxford Club | Ad
Studies by Harvard, Vanderbilt, the U.S. Chamber of Commerce, Reuters, Fidelity and Deutsche Bank all confirm one simple strategy leads to outsized profits for investors.
Yet the elites in Washington want to ban this moneymaking method!
Join Alexander Green and Bill O'Reilly on June 9 at 8 p.m. ET to discover perhaps the greatest (yet controversial) profit strategy of our lifetimes.
>>>
SEC Filings (Institutional Ownership Changes) for AVITA Medical (ASX:AVH)
AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and proprietary platform technology provides treatment solutions derived from the regenerative properties of a patient's own skin. Its lead product is RECELL System, a device that enables healthcare professionals to produce a suspension of Spray-On Skin cells using a small sample of the patient's own skin for use in the treatment of acute thermal burns in patients eighteen years and older. The company has a research collaboration with the University of Colorado School of Medicine to establish pre-clinical proof-of-concept for a spray-on treatment of genetically corrected cells; and a research collaboration with Houston Methodist Research Institute to explore molecular reversal of cellular aging through a novel cell suspension delivery system. The company was formerly known as AVITA Therapeutics, Inc. and changed its name to AVITA Medical Inc. in December 2020. AVITA Medical Inc. was incorporated in 2000 and is based in Valencia, California.
Read More on AVITA Medical
Today's Range
Now: N/A
50 Day Range
MA: N/A
52 Week Range
Now: N/A
Volume
27,281,329 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Beta
N/A
Who are the company insiders with the largest holdings of AVITA Medical?
